Turkmenistan Medical Device Registration: Application Form and Application Letter

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

In Turkmenistan, a national registration or re-registration filing for a medical device is built on two documents that function strictly as a pair:

  • The application form (Application) — completed in the approved format established for registration or re-registration of the product; and
  • The application letter — issued by the applicant, who is the registration certificate holder, and addressed to the competent authority.

Both documents must be accompanied by a Russian translation. In practical terms, the application form is the structured carrier of all product and applicant data, while the application letter expresses the intent and commitments of the holder in narrative form. Neither document can substitute for the other, and a filing that lacks either one is incomplete on arrival. This matters because the preliminary review that opens the registration procedure is a documentary completeness check, and these two documents are the first items the reviewer sees. Manufacturers should therefore treat the form and the letter as a single preparation package, drafted together, translated together, and signed by the correct entity before anything else in the dossier is finalized.

2. Legal basis

RegulationReference numberPublication dateProvisions
Law of Turkmenistan on the Supply of MedicinesNo. 319-VJanuary 12, 2016National registration procedure and documentation requirements
Regulation on State Registration of Medicines and Medical DevicesNo public number (approved by the Ministry of Health)Current versionApplication form format; application letter; list of documents requiring Russian translation

3. Expert insights

Insight 1: The approved format means you cannot design your own form.

The regulatory language explicitly requires an application form in the approved format. This is part of the national format archive system: the template itself is issued by the competent authority, and applicants are not permitted to redesign or approximate it. The form is a state-format document, not a commercial template, and deviations in layout, field structure, or page composition are treated as formal defects. The practical move is to obtain the current version of the form through the local representative, confirm that it matches the version currently accepted by the authority, and complete it without altering its structure. Forms downloaded from unofficial sources or recycled from previous projects frequently turn out to be outdated revisions.

Insight 2: The application letter is issued by the applicant and holder, not by the manufacturer.

Where the holder is a resident entity, the manufacturer and the applicant may coincide. But under the non-resident holder plus local representative structure, the application letter is issued by the holder, and the local representative submits it on the basis of a power of attorney. Signing by the wrong entity — for example, by the factory rather than the certificate holder — creates a mismatch between the signatory and the POA authorization chain that reviewers will flag. Clarify the issuing entity at the outset so that the signature block matches the POA chain exactly.

Insight 3: Both the application letter and the application form require Russian translations.

The regulatory language places the applicant’s application letter and the application form together on the list of documents that must be submitted with a Russian translation. These are the first two documents to process in the language matrix for the dossier. Translations should be complete, including every field of the form, and should be checked against the source text so that product names, addresses, and legal identifiers carry over without variation.

Insight 4: The data on the application form persists across the entire certificate lifecycle.

The product name, model designations, manufacturer name and address, and classification entered on the form will enter the state register of medical devices and will ultimately appear on the registration certificate itself. Any subsequent change to this information must go through the change procedure described in the dedicated change chapter of this series. That procedure takes time and administrative effort, which is why the form should be treated as a document to be filled in correctly once, not a draft to be corrected later.

Insight 5: Completeness of the form determines whether acceptance happens at all.

As explained in the chapter on the registration procedure, the preliminary review examines documentary completeness, and the application form is the first document checked. A form with missing fields will cause acceptance to fail, and the 180-calendar-day review clock will not start. Time lost at this stage is entirely avoidable with a disciplined internal pre-check before submission.

4. Practical recommendations

  1. Obtain the current official version of the application form through the local representative and never use a self-made form.
  2. Confirm the issuing entity of the application letter and align it with the POA authorization chain.
  3. Prepare the Russian translation of the application letter and the application form together.
  4. Fill in the application form accurately in one pass, because subsequent corrections must go through the change procedure.
  5. Self-check the form against the acceptance threshold for completeness before submission.

5. Verification checklist

  • □ The current official version of the application form has been obtained.
  • □ The issuing entity of the application letter matches the POA authorization chain.
  • □ Russian translations have been attached to both documents.
  • □ The application form data has been completed accurately in one pass (name, models, manufacturer, classification).
  • □ A completeness self-check against the acceptance threshold has been performed.

Regulatory information verified as of October 30, 2026. The content cited in this article was cross-checked against the Law of Turkmenistan on the Supply of Medicines No. 319-V of January 12, 2016 and the Regulation on State Registration of Medicines and Medical Devices approved by the Ministry of Health (the application form must be in the approved format, the application letter must be issued by the applicant, and both must be accompanied by a Russian translation); the specific fields of the form follow the current official version.

  • GRZAN local resources in Turkmenistan: GRZAN supports manufacturers, importers, and authorized representatives by coordinating licensed local import entities and authorized representative resources, covering national registration submissions, the consular legalization chain for documents, sample delivery, liaison with mandatory TDS certification, and customs clearance support.
  • Service capabilities: classification assessment, registration pathway selection, preparation of dossiers in the approved national formats, consular legalization and notarization, preparation of test and stability documentation, organization of GMP and ISO 13485 evidence, change procedures and certificate renewal, vigilance and post-market maintenance.
  • Contact: info@grzanglobal.com.

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail